DPP-4 inhibitors are generally well tolerated, and their favourable safety profile is one reason they are widely used in clinical practice
No insurance, no membership fee, and service extends to all 50 states
If a clinician recommends that you try a GLP-1 to lose weight or treat diabetes, which drug they recommend first will likely depend on your health conditions, starting weight and more practically what your insurance will cover
Stopping before 16 weeks means quitting before the inflection point where results become obvious
Diabetes Obes Metab 22(8):13781387
I hope the GLP-1 manufacturers can continue to meet the demand and work with payers to make these affordable to the people that need them." In response to past shortages, Novo Nordisk has introduced a new artificial intelligence-powered app called Find My Meds, created to help patients locate Wegovy at nearby pharmacies